METABOLIC MODULATION OF GLIOBLASTOMA WITH DICHLOROACETATE PDF DOWNLOAD
17 Jan Keywords: bicarbonate, dichloroacetate, glioma, hyperpolarized 13C therapies and metabolic modulation, with improved ef- fectiveness have. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Metabolic modulation of glioblastoma with dichloroacetate. Metabolic modulation as a novel Keywords: cancer, metabolic, apoptosis, dichloroacetate, glycolysis .. modulation of glioblastoma with dichloroacetate.
|Published (Last):||17 August 2017|
|PDF File Size:||10.92 Mb|
|ePub File Size:||4.67 Mb|
|Price:||Free* [*Free Regsitration Required]|
Log in through your institution Log in via OpenAthens.
We sought to characterize the necessity of complex I inhibition in the efficacy of the combination. Metformin—mode of action and clinical implications for diabetes and cancer.
We tested whether the small-molecule and metabolic modulation of glioblastoma with dichloroacetate drug sichloroacetate DCA can reverse this cancer-specific metabolic metqbolic mitochondrial remodeling in glioblastoma.
A role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation. Mitaplatin, a potent fusion of cisplatin and modulatiom orphan drug dichloroacetate. The anti-diabetic drug metformin has displayed robust activity towards cancer, both cell-autonomous and indirect metabolic effects [ 50 — 53 ].
This metabolic remodeling is accompanied by mitochondrial hyperpolarization.
We were able to replicate metformin potentiation of superoxide production with DCA treatment in our glioblastoma cells Fig 3B. As mitochondrial metabolism is intrinsically linked to redox balance, a known sensitivity of cancer, targeting the organelle is likely to prove successful [ 7 ].
Metabolic Modulation of Glioblastoma with Dichloroacetate
Blots were washed with TBS-T and incubated with goat-anti-mouse and goat-anti-rabbit secondary antibodies coupled to horseradish peroxidase HRP.
Webster – University of Alberta A. A phase I open-labeled, single-arm, dose-escalation, study of dichloroacetate DCA in patients with advanced solid tumors. This study was funded through a charitable donation from Scivation, Inc. Michelakis – Metabolic modulation of glioblastoma with dichloroacetate of Alberta G.
Metabolic modulation of glioblastoma with dichloroacetate tumors, including the aggressive primary glioblastomq cancer glioblastoma multiforme, glioblaatoma resistance to cell death, in part as a result of a switch from mitochondrial oxidative phosphorylation to cytoplasmic glycolysis. Moreover, DCA promoted stable disease in patients with malignant brain tumors in a Phase I trial [ 22 ]. Pharmacological activation of this complex with the small molecule PDK inhibitor, DCA, has been shown to reduce tumor growth and promote cancer cell death through induction of oxidative stress [ 1819 ].
To determine if this induction of oxidative gliolbastoma is associated with cytotoxicity, we assayed VM-M3 viability following DCA treatment. Ionizing radiation as well as many dichliroacetate chemotherapies such as 5-fluorouracil and doxorubicin elicit cytotoxicity towards cancer cells in part through induction of ROS and overwhelming cellular redox balance [ 7 ].
Navigation metabolic modulation of glioblastoma with dichloroacetate Toggle navigation FactPub. This suggests differing mechanisms of complex I inhibition; the mechanism of metformin action at complex I is not fully understood.
Metabolic modulation may be a viable therapeutic approach in the treatment of glioblastoma. Metformin enhances DCA cytotoxicity through further induction of oxidative stress Given the observed association between induction of ROS and cytotoxicity with DCA treatment, we hypothesized that the addition of an insult to the electron transport chain would further enhance glloblastoma anti-cancer activity.
Log in to view the full text metabolic modulation of glioblastoma with dichloroacetate AAAS login.
As such, much of the investigative focus on DCA has shifted towards its efficacy as an adjuvant to established therapies.
Metabolic Modulation of Glioblastoma with Dichloroacetate – Dimensions
Acknowledgments We would like to thank Dr. Science Translational Medicine 12 May Nat Rev Drug Discov. Our data indicate that metformin enhancement of DCA cytotoxicity is dependent on complex I inhibition. Metformin repositioning as metabolic modulation of glioblastoma with dichloroacetate agent: The absorbance at nm was then read using a plate reader BioTek ELx Changes in gene expression profiles of multiple myeloma cells induced by arsenic trioxide ATO: You are currently viewing wifh abstract.
Metabolic modulation of glioblastoma with dichloroacetate. Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology. DCA therapy also inhibited the hypoxia-inducible factor-1alpha, promoted p53 activation, and suppressed angiogenesis both in vivo and in vitro.
Association of reactive oxygen species levels and radioresistance in cancer stem cells. However, where metformin is well tolerated clinically, phenformin has been removed from the clinic over concerns of lactic acidosis [ 56 ]. Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer. Michelakis Journal of Molecular Medicine metabolic modulation of glioblastoma with dichloroacetate Writing — original draft: MitoSox Red fluorescent microscopy indicated a greater than two-fold increase in fluorescence intensity following 1-hour DCA treatment, indicating enhanced mitochondrial superoxide production Fig 1C.
The culture media was then replaced and treatment applied for 24 hours. We tested whether the small-molecule and orphan drug dichloroacetate DCA can modulaton this cancer-specific metabolic and mitochondrial remodeling in glioblastoma.
Targeting hexokinase II to mitochondria to modulate energy metabolism and reduce ischaemia-reperfusion injury in heart. Glioblzstoma metabolic modulation of glioblastoma with dichloroacetate an open access article distributed under the terms of the Creative Commons Attribution Licensewhich permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Metabolic modulation of glioblastoma with dichloroacetate. – PubMed – NCBI
This coincided with synergistic cytotoxicity that required the increase in oxidative stress. Therefore, it is vital to identify adjuvant agents that further enhance oxidative stress to overwhelm the antioxidant system and overcome this mechanism of resistance.
Concurrently, these energetic and redox stresses dictate a compensatory increase in antioxidant capacity that permits cancer cell resilience and proliferation [ 4 ]. Moderate oxidative stress can therefore contribute to the genomic metabolic modulation of glioblastoma with dichloroacetate that is characteristic of cancer as well as enhance oncogenic metabolic modulation of glioblastoma with dichloroacetate through oxidation of constituents of mitogenic pathways [ 5 ].
This combination may be particularly useful as an adjuvant to current pro-oxidant therapies, for which efficacy is often fleeting due to chemoresistant mechanisms that restrict mitochondrial oxidation [ 13141620 ].
Metformin potentiated DCA-induced superoxide production, which was required for enhanced cytotoxicity towards VM-M3 cells observed with the combination.